{
  "symbol": "INSM",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biopharmaceutical sector", "focus on rare diseases"],
    "riskScore": 7,
    "reason": "Insmed operates in the biopharmaceutical sector, which is prone to speculation, especially with its focus on rare diseases."
  }
}